000			02050 a2200601 4500
005			20250513190621.0
264		0	_c19990817
008			199908s 0 0 eng d
022			_a0969-7128
024	7		_a10.1038/sj.gt.3300833 _2doi
040			_aNLM _beng _cNLM
100	1		_aStewart, A K
245	0	0	_aAdenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. _h[electronic resource]
260			_bGene therapy _cMar 1999
300			_a350-63 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenoviridae _xgenetics
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aBreast Neoplasms _ximmunology
650	0	4	_aCD3 Complex _ximmunology
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCD8 Antigens _ximmunology
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aInjections, Intralesional
650	0	4	_aInterleukin-2 _xgenetics
650	0	4	_aLymphocyte Count
650	0	4	_aLymphocytes, Tumor-Infiltrating _ximmunology
650	0	4	_aMelanoma _ximmunology
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aSkin Neoplasms _ximmunology
700	1		_aLassam, N J
700	1		_aQuirt, I C
700	1		_aBailey, D J
700	1		_aRotstein, L E
700	1		_aKrajden, M
700	1		_aDessureault, S
700	1		_aGallinger, S
700	1		_aCappe, D
700	1		_aWan, Y
700	1		_aAddison, C L
700	1		_aMoen, R C
700	1		_aGauldie, J
700	1		_aGraham, F L
773	0		_tGene therapy _gvol. 6 _gno. 3 _gp. 350-63
856	4	0	_uhttps://doi.org/10.1038/sj.gt.3300833 _zAvailable from publisher's website
999			_c10392853 _d10392853